Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hims & Hers Health Inc
(NY:
HIMS
)
23.11
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hims & Hers Health Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Hims & Hers Health Stock Soared This Week: Here's Why
June 01, 2024
The company is still riding momentum from its recent weight loss drug announcement.
Via
The Motley Fool
Looking At Hims & Hers Health's Recent Unusual Options Activity
May 31, 2024
Via
Benzinga
SPDR ETF Report For Thursday, May 30
May 31, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Thursday, May 30.
Via
Talk Markets
Topics
ETFs
SPDR ETF Report For Wednesday, May 29
May 30, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Wednesday, May 29.
Via
Talk Markets
Topics
ETFs
Smart Money Is Betting Big In HIMS Options
May 29, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
May 23, 2024
Via
Benzinga
Navigating 10 Analyst Ratings For Hims & Hers Health
May 22, 2024
Via
Benzinga
Hims & Hers Is Changing the Game
May 22, 2024
GLP-1s could be the product that pushes Hims & Hers over the edge to mainstream adoption.
Via
The Motley Fool
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
May 20, 2024
Via
Benzinga
SPDR ETF Report For Tuesday, May 28
May 29, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Tuesday, May 28.
Via
Talk Markets
Topics
ETFs
A New Name in Weight Loss Drugs
May 28, 2024
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Via
The Motley Fool
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
May 28, 2024
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.
Via
The Motley Fool
The Ultimate Growth Stock to Buy With $20 Right Now
May 26, 2024
I challenge you to name another $20 stock with more long-term potential.
Via
The Motley Fool
7 Stocks to Dominate in the Next Economic Upturn
May 24, 2024
Discover the top stocks to buy for the next economic upturn, carefully selected for their robust growth potential.
Via
InvestorPlace
Is Hims & Hers Health Stock a Buy?
May 13, 2024
A six-point argument that shares are a table-pounding opportunity worth scooping up now.
Via
The Motley Fool
2 Incredible Growth Stocks to Buy Hand Over Fist
May 08, 2024
These two healthcare growth stocks could have a lot more room to run.
Via
The Motley Fool
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
May 23, 2024
The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders.
Via
InvestorPlace
The Growth Stock Shuffle: 2 to Ditch and 1 to Own
May 22, 2024
Investing in growth stocks requires a keen eye for profitability. Ditch these two unprofitable stocks and embrace this telehealth winner.
Via
InvestorPlace
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
May 21, 2024
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."
Via
Benzinga
Topics
ETFs
Meme Stocks GameStop, AMC Fade In Interest After Roaring Kitty Exit: Here's What WallStreetBets Is Eyeing Next
May 21, 2024
Retail traders could be shifting away from meme stocks to several other stocks seeing strong interest on WallSteetBets.
Via
Benzinga
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
May 20, 2024
HIMS stock is catching a bid after Hims & Hers announced that it would begin providing access to GLP-1 weight-loss injections.
Via
InvestorPlace
Tech Surge Boosts Nasdaq To Record Highs
May 20, 2024
The Nasdaq Composite Index is up triple digits and marking new record highs, thanks to rising tech stocks.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Stocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets Monday?
May 20, 2024
Wall Street rallies on Monday as major US indices reach fresh record highs. Metal commodities surge, Treasury yields stay stable. Cruise stocks soar.
Via
Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 20, 2024
Via
Benzinga
Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars
May 20, 2024
Hims & Hers Health expands its weight loss offerings with GLP-1 injections and oral medication kits. Pricing starts at $79/month.
Via
Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
Via
Benzinga
Stock Market Mayhem: 3 Companies Ready to Shake Things Up
May 20, 2024
As the stock market heats up, consider investing in these three disruptive stocks to buy, likely to offer substantial long-term gains.
Via
InvestorPlace
5 Medical Info Systems Stocks To Buy For Stable Returns
May 11, 2024
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024.
Via
Talk Markets
Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?
May 11, 2024
The stock is one of the cheapest high-growth stocks around.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.